GGrantIndex
← Leaderboards

Otoniel Martinez-Maza

University Of California Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗
$22,455,072
Attributed
$38,064,048
Total exposure
10
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6M · FY2005–21
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$38,064,048 · 10

By mechanism

U01$26,292,273 · 2
R01$11,375,802 · 6
R21$395,973 · 1
P50$0 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Hiv Infections”

Research focus

Hiv InfectionsMolecularAcquired Immunodeficiency SyndromePersonsMalignant NeoplasmsChronicB-LymphocytesCytokineDiagnosisCellsLesionPlaySerumS LymphomaInfectionIn VivoImmuneB-Cell ActivationAntibodiesEventLeadHuman Herpesvirus 4EtiologyB-Cell Nonhodgkins Lymphoma

Grant awards (49)

The Role of Follicular CD8+ T Cells in Pathogenesis of AIDS-NHL$54,592
R01 · FY2021 · CA
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL$629,238
R01 · FY2020 · CA
Los Angeles CRS for the MACS/WIHS Combined Cohort Study$46,610
U01 · FY2020 · HL
Los Angeles CRS for the MACS/WIHS Combined Cohort Study$3,900,000
U01 · FY2019 · HL
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL$621,421
R01 · FY2019 · CA
Los Angeles CRS for the MACS/WIHS Combined Cohort Study$329,538
U01 · FY2019 · HL
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL$106,027
R01 · FY2019 · CA
Los Angeles CRS for the MACS/WIHS Combined Cohort Study$72,015
U01 · FY2019 · HL
Natural History of AIDS in Homosexual Men$3,868,288
U01 · FY2018 · AI
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL$860,660
R01 · FY2018 · CA
Natural History of AIDS in Homosexual Men$4,616,765
U01 · FY2017 · AI
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL$502,591
R01 · FY2017 · CA
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$319,550
R01 · FY2017 · CA · contact PI
The effect of statins on B cell dysfunction in HIV infection$215,985
R21 · FY2017 · CA · contact PI
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$84,395
R01 · FY2017 · CA · contact PI
Natural History of AIDS in Homosexual Men$4,586,875
U01 · FY2016 · AI
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL$504,843
R01 · FY2016 · CA
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$319,550
R01 · FY2016 · CA · contact PI
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL$196,920
R01 · FY2016 · CA
The effect of statins on B cell dysfunction in HIV infection$179,988
R21 · FY2016 · CA · contact PI
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$99,797
R01 · FY2016 · CA · contact PI
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$93,771
R01 · FY2016 · CA · contact PI
Natural History of AIDS in Homosexual Men$4,448,266
U01 · FY2015 · AI
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$319,550
R01 · FY2015 · CA · contact PI
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$172,226
R01 · FY2015 · CA · contact PI
Natural History of AIDS in Homosexual Men$4,423,916
U01 · FY2014 · AI
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$309,964
R01 · FY2014 · CA · contact PI
HIV driven B cell activation: role in the genesis of AIDS-related lymphoma$93,771
R01 · FY2014 · CA · contact PI
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma$319,550
R01 · FY2013 · CA · contact PI
Prediagnostic Markers of Immune Activation and Viral Infection and Risk of NHL$392,020
R01 · FY2009 · CA · contact PI
Immune Dysfunction and AIDS-associated B Cell Lymphoma$279,804
R01 · FY2009 · CA · contact PI
Prediagnostic Markers of Immune Activation and Viral Infection and Risk of NHL$395,273
R01 · FY2008 · CA · contact PI
Immune Dysfunction and AIDS-associated B Cell Lymphoma$279,804
R01 · FY2008 · CA · contact PI
Immune Dysfunction and AIDS-associated B Cell Lymphoma$163,086
R01 · FY2008 · CA · contact PI
Immune Dysfunction and AIDS-associated B Cell Lymphoma$123,200
R01 · FY2008 · CA · contact PI
Prediagnostic Markers of Immune Activation and Viral Infection and Risk of NHL$358,114
R01 · FY2007 · CA · contact PI
Immune Dysfunction and AIDS-associated B Cell Lymphoma$279,804
R01 · FY2007 · CA · contact PI
Immune Dysfunction and AIDS-associated B Cell Lymphoma$163,086
R01 · FY2007 · CA · contact PI
Prediagnostic Markers of Immune Activation and Viral Infection and Risk of NHL$467,191
R01 · FY2006 · CA · contact PI
Immune Dysfunction and AIDS-associated B Cell Lymphoma$288,161
R01 · FY2006 · CA · contact PI
Immune Dysfunction and AIDS-associated B Cell Lymphoma$295,095
R01 · FY2005 · CA
Molecular Epidemiology of AIDS-Associated Lymphoma$370,250
R01 · FY2004 · CA
Molecular Epidemiology of AIDS-Associated Lymphoma$364,907
R01 · FY2003 · CA
Molecular Epidemiology of AIDS-Associated Lymphoma$81,273
R01 · FY2003 · CA
Molecular Epidemiology of AIDS-Associated Lymphoma$372,162
R01 · FY2002 · CA
Epidemiology of lymphoma in HIV infected populations$0
P50 · FY2002 · CA
IMMUNE DYSFUNCTION AND AIDS ASSOCIATED B CELL LYMPHOMA$408,819
R01 · FY2001 · CA
IMMUNE DYSFUNCTION AND AIDS ASSOCIATED B CELL LYMPHOMA$400,814
R01 · FY2000 · CA
MOLECULAR EPIDEMIOLOGY OF AIDS-ASSOCIATED LYMPHOMA$284,523
R01 · FY2000 · CA